Citations Report

Journal of Molecular Biomarkers & Diagnosis : Citations & Metrics Report

Articles published in Journal of Molecular Biomarkers & Diagnosis have been cited by esteemed scholars and scientists all around the world.

Journal of Molecular Biomarkers & Diagnosis has got h-index 19, which means every article in Journal of Molecular Biomarkers & Diagnosis has got 19 average citations.

Following are the list of articles that have cited the articles published in Journal of Molecular Biomarkers & Diagnosis.

	2022	2021	2020	2019	2018
Year wise published articles	61	64	25	14	37
Year wise citations received	182	206	253	221	222

Journal total citations count	2054
Journal impact factor	2.04
Journal 5 years impact factor	5.42
Journal cite score	5.28
Journal h-index	19
Journal h-index since 2018	14

Important citations

Carcereny, Enric, Alonso Fernández-Nistal, Araceli López, Carmen Montoto, Andrea Naves, Cristina Segú-Vergés, Mireia Coma, Guillem Jorba, Baldomero Oliva, and Jose Manuel Mas. "Head to head evaluation of second generation ALK inhibitors brigatinib and alectinib as first-line treatment for ALK+ NSCLC using an in silico systems biology-based approach." Oncotarget 12, no. 4 (2021): 316. View at Publisher View at Google Scholar View at Indexing
Martín-Segura, Adrián, Álvaro Casadomé-Perales, Pietro Fazzari, José Manuel Mas, Laura Artigas, Raquel Valls, Angel R. Nebreda, and Carlos G. Dotti. "Aging increases hippocampal DUSP2 by a membrane cholesterol loss-mediated RTK/p38MAPK activation mechanism." Frontiers in neurology 10 (2019): 675. View at Publisher View at Google Scholar View at Indexing
Sayeed, H. Naziya, and Mohamed Adil AA. "Targeting Immunocheckpoint In The Tumor Microenvironment And Cancer Immunotherapy." Annals of the Romanian Society for Cell Biology (2020): 297-316. View at Publisher View at Google Scholar View at Indexing
Konhäuser, Matthias. "Dynamic Polysaccharide-based Nanoparticles for Advanced Drug Delivery Applications." PhD diss., Johannes Gutenberg-Universität Mainz, 2019. View at Publisher View at Google Scholar View at Indexing
Balasubramanian, Sriram, Songbai Wang, Christopher Major, Brendan Hodkinson, Michael Schaffer, Laurie H. Sehn, Peter Johnson et al. "Comparison of immunohistochemistry and gene expression profiling subtyping for diffuse large B?cell lymphoma in the phase III clinical trial of R?CHOP±ibrutinib." British Journal of Haematology (2021). View at Publisher View at Google Scholar View at Indexing
Yang, Haiyan, Bing Xiang, Yuqin Song, Huilai Zhang, Weili Zhao, Dehui Zou, Fangfang Lv et al. "Zanubrutinib Monotherapy for Relapsed or Refractory Non-Germinal Center Diffuse Large B-Cell Lymphoma." Blood Advances (2021). View at Publisher View at Google Scholar View at Indexing
ERKAL, Burçin, Ceyda HAYRETDA? ÖRS, Sevgi KALKANLI TA?, Nisa Begüm ERDO?AN, Arzum ?AMLI, and Ender CO?KUNPINAR. "Immunotherapeutic Evaluation of Cancer Vaccines." Ilek Academic Journal 1, no. 1: 1-11. View at Publisher View at Google Scholar View at Indexing
Nowakowski, Grzegorz S., Tatyana Feldman, Lisa M. Rimsza, Jason R. Westin, Thomas E. Witzig, and Pier Luigi Zinzani. "Integrating precision medicine through evaluation of cell of origin in treatment planning for diffuse large B-cell lymphoma." Blood cancer journal 9, no. 6 (2019): 1-10. View at Publisher View at Google Scholar View at Indexing
Carels, Nicolas, Alessandra Jordano Conforte, Carlyle Ribeiro Lima, and Fabricio Alves Barbosa da Silva. "Challenges for the optimization of drug therapy in the treatment of cancer." In Networks in Systems Biology, pp. 163-198. Springer, Cham, 2020. View at Publisher View at Google Scholar View at Indexing
Younes, Anas, Laurie H. Sehn, Peter Johnson, Pier Luigi Zinzani, Xiaonan Hong, Jun Zhu, Caterina Patti et al. "Randomized phase III trial of ibrutinib and rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone in non–germinal center B-cell diffuse large B-cell lymphoma." Journal of clinical oncology 37, no. 15 (2019): 1285. View at Publisher View at Google Scholar View at Indexing
Smalley, Munisha, Michelle Przedborski, Saravanan Thiyagarajan, Moriah Pellowe, Amit Verma, Nilesh Brijwani, Debika Datta et al. "Integrating systems biology and an ex vivo human tumor model elucidates PD-1 blockade response dynamics." Iscience 23, no. 6 (2020): 101229. View at Publisher View at Google Scholar View at Indexing
Okuyama, Tomoko, Jun Shirakawa, Takashi Nakamura, Takayo Murase, Daisuke Miyashita, Ryota Inoue, Mayu Kyohara, Yu Togashi, and Yasuo Terauchi. "Association of the plasma xanthine oxidoreductase activity with the metabolic parameters and vascular complications in patients with type 2 diabetes." Scientific reports 11, no. 1 (2021): 1-13. View at Publisher View at Google Scholar View at Indexing
Mirzaei, Sepideh, Mohammad Hossein Gholami, Farid Hashemi, Amirhossein Zabolian, and Ali Zarrabi. "Advances in understanding the role of P-gp in doxorubicin resistance: Molecular pathways, therapeutic strategies, and prospects." (2021). View at Publisher View at Google Scholar View at Indexing
Kawachi, Yusuke, Yuya Fujishima, Hitoshi Nishizawa, Hirofumi Nagao, Takashi Nakamura, Seigo Akari, Takayo Murase et al. "Plasma xanthine oxidoreductase activity in Japanese patients with type 2 diabetes across hospitalized treatment." Journal of diabetes investigation 12, no. 8 (2021): 1512-1520. View at Publisher View at Google Scholar View at Indexing
Furuhashi, Masato, Masayuki Koyama, Yukimura Higashiura, Takayo Murase, Takashi Nakamura, Megumi Matsumoto, Akiko Sakai et al. "Differential regulation of hypoxanthine and xanthine by obesity in a general population." Journal of diabetes investigation 11, no. 4 (2020): 878-887. View at Publisher View at Google Scholar View at Indexing
Furuhashi, Masato. "New insights into purine metabolism in metabolic diseases: role of xanthine oxidoreductase activity." American Journal of Physiology-Endocrinology and Metabolism 319, no. 5 (2020): E827-E834. View at Publisher View at Google Scholar View at Indexing
Pathania, Anup S., Philip Prathipati, and Kishore B. Challagundla. "New insights into exosome mediated tumor-immune escape: Clinical perspectives and therapeutic strategies." Biochimica et Biophysica Acta (BBA)-Reviews on Cancer (2021): 188624. View at Publisher View at Google Scholar View at Indexing
Powter, Branka, Sarah A. Jeffreys, Heena Sareen, Adam Cooper, Daniel Brungs, Joseph Po, Tara Roberts et al. "Human TERT promoter mutations as a prognostic biomarker in glioma." Journal of cancer research and clinical oncology (2021): 1-11. View at Publisher View at Google Scholar View at Indexing
Mothkur, Rashmi, and K. M. Poornima. "Machine learning will transfigure medical sector: a survey." In 2018 International Conference on Current Trends towards Converging Technologies (ICCTCT), pp. 1-8. IEEE, 2018. View at Publisher View at Google Scholar View at Indexing
Ding, Pei N., Therese Becker, Victoria Bray, Wei Chua, Yafeng Ma, Bo Xu, David Lynch, Paul de Souza, and Tara Roberts. "Plasma next generation sequencing and droplet digital PCR?based detection of epidermal growth factor receptor (EGFR) mutations in patients with advanced lung cancer treated with subsequent?line osimertinib." Thoracic cancer 10, no. 10 (2019): 1879-1884. View at Publisher View at Google Scholar View at Indexing
Prev 1 2 3 4 5 6 7 8 9 10 11 12 13 ... 28 29 Next »

Relevant Topics

Journal Highlights

Google Scholar citation report

Citations: 2054

Journal of Molecular Biomarkers & Diagnosis received 2054 citations as per Google Scholar report

Journal of Molecular Biomarkers & Diagnosis peer review process verified at publons

Indexed In

CAS Source Index (CASSI)
Index Copernicus
Google Scholar
Open J Gate
Genamics JournalSeek
China National Knowledge Infrastructure (CNKI)
Ulrich's Periodicals Directory
RefSeek
Hamdard University
EBSCO A-Z
OCLC- WorldCat
Publons
Geneva Foundation for Medical Education and Research
Euro Pub

Journal of Molecular Biomarkers & Diagnosis